Literature DB >> 22502710

Bufalin, a traditional oriental medicine, induces apoptosis in human cancer cells.

Noriyuki Takai1, Naoko Kira, Terukazu Ishii, Toshie Yoshida, Masakazu Nishida, Yoshihiro Nishida, Kaei Nasu, Hisashi Narahara.   

Abstract

Bufalin is a traditional oriental medicines which induces apoptosis in some lines of human tumor cells. It constitutes the major digoxin-like immunoreactive component of Chan Su, obtained from the skin and parotid venom glands of toads. Bufalin is cardioactive C-24 steroids that exhibits a variety of biological activities, such as cardiotonic, anaesthetic, blood pressure stimulatory, respiratory and antineoplastic effects. In terms of its anti-tumor activity, bufalin has been demonstrated to inhibit the growth of tumors, such as endometrial and ovarian cancers. This commentary introduces biologic and therapeutic effects of bufalin in treating some cancers. The compound is able to mediate inhibition of cell growth, cell cycle arrest, apoptosis, and expression of genes related to the malignant phenotype in human cancer cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22502710     DOI: 10.7314/apjcp.2012.13.1.399

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  24 in total

1.  Bufalin Enhances the Cytotoxity of Human Multiple Myeloma Cells H929 to AKT Inhibitor MK2206: The Role of Protein AKT Phosphorylation.

Authors:  He Huang; Xiao-Ji Lin; Ying Lin; Ron-Xin Yao; Mu-Qing He
Journal:  Indian J Hematol Blood Transfus       Date:  2017-09-30       Impact factor: 0.900

2.  Bufalin exerts inhibitory effects on IL-1β-mediated proliferation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  Yue-wen Chang; Yong-fang Zhao; Yue-long Cao; Wei Gu; Jian Pang; Hong-sheng Zhan
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

3.  Hyperthermia and radiation reduce the toxic side-effects of bufadienolides for cancer therapy.

Authors:  Heba Emam; Alaa Refaat; Paras Jawaid; Mati Ur Rehman; Peng Li; Qing-Li Zhao; Takashi Kondo
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

4.  Bufalin Enhances Immune Responses in Leukemic Mice Through Enhancing Phagocytosis of Macrophage In Vivo.

Authors:  Yung-Luen Shih; Jiann-Shang Chou; Yung-Liang Chen; Shu-Ching Hsueh; Hsueh-Yu Chung; Mei-Hui Lee; Chao-Ping Chen; Ming-Zhe Lee; Hsin-Tu Hou; Hsu-Feng Lu; Kuo-Wei Chen; Jing-Gung Chung
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

5.  A study on the effect of aqueous extract of Lobelia chinensis on colon precancerous lesions in rats.

Authors:  Shao-Rong Han; Xiao-Yan Lv; Yan-Ming Wang; Hai Gong; Cong Zhang; An-Na Tong; Ning Yan
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-10-03

6.  Tumor-Targeted Delivery of Bufalin-Loaded Modified Albumin-Polymer Hybrid for Enhanced Antitumor Therapy and Attenuated Hemolysis Toxicity and Cardiotoxicity.

Authors:  Ying Xu; Lei Tang; Peng Chen; Mei Chen; Miaomiao Zheng; Feng Shi; Yanchun Wang
Journal:  AAPS PharmSciTech       Date:  2021-04-20       Impact factor: 3.246

7.  Bufalin suppresses endometriosis progression by inducing pyroptosis and apoptosis.

Authors:  Yeon Jean Cho; Jiyeun E Lee; Mi Jin Park; Bert W O'Malley; Sang Jun Han
Journal:  J Endocrinol       Date:  2018-04-10       Impact factor: 4.286

8.  Targeting poly (ADP-ribose) polymerase partially contributes to bufalin-induced cell death in multiple myeloma cells.

Authors:  He Huang; Yang Cao; Wei Wei; Wei Liu; Shao-Yong Lu; Yu-Bao Chen; Yan Wang; Hua Yan; Ying-Li Wu
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

9.  Anticancer effects of bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagy.

Authors:  Qing Miao; Lin-Lin Bi; Xin Li; Shan Miao; Jin Zhang; Song Zhang; Qian Yang; Yan-Hua Xie; Jian Zhang; Si-Wang Wang
Journal:  Int J Mol Sci       Date:  2013-01-11       Impact factor: 5.923

10.  Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells.

Authors:  Dong-Ze Qiu; Zhou-Ji Zhang; Wei-Zhong Wu; Yun-Ke Yang
Journal:  BMC Complement Altern Med       Date:  2013-07-19       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.